1. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis : a 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-1582.
2. Wilske KR, Healey LA. Remodeling the pyramid : a concept whose time has come. J Rheumatol 1989;16:565-567.
3. Kaarela K, Kauppi MJ, Lehtinen KE. The value of the ACR 1987 criteria in very early rheumatoid arthritis. Scand J Rheumatol 1995;24:279-281.
4. van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34:Suppl. 74-78.
5. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early : a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002;46:357-365.
6. Brennan P, Harrison B, Barrett E, Chakravarty K, Scott D, Symmons D, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis : prospective cohort study. BMJ 1996;313:471-476.
7. The HERA Study Group. A randomized trial of hydroxychloroquine in early rheumatoid arthritis : the HERA Study. Am J Med 1995;98:156-168.
8. Abu-Shakra M, Toker R, Flusser D, Flusser G, Friger MS, Buskila D, et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 1998;41:1190-1195.
9. van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Schenk Y, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
10. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, Esdaile JM, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis : a 3 year follow up on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623-629.
11. Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis:early presenters continue to do well. J Rheumatol 1998;25:1072-1077.
12. Kroot EJ, van Leeuwen MA, van Rijswijk MH, Prevoo ML, Van't Hof MA, van Riel PL, et al. No increased mortality in patients with rheumatoid arthritis : up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-958.
13. Baigent C, Patrono C. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease : a reappraisal. Arthritis Rheum 2003;48:12-20.
14. van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis : clinical efficacy, disease-modifying properties, and side effects : a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.
15. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis : 2001 update. Arthritis Rheum 2001;44:1496-1503.
16. van de Putte LBA. Single agents in early rheumatoid arthritis : results of key randomized trials of single agents in early rheumatoid arthritis. J Rheumatol 2002;29:Suppl. 13-19.
17. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy / toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum 1992;35:1117-1112.
18. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van der Linden S, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-318.
19. Felson DT, Anderson JJ, Meenan RF. The efficacy and toxicity of combination therapy in rheumatoid arthritis. A meta-analysis. Arthritis Rheum 1994;37:1487-1491.
20. Lipsky PE, van der Heijde DM, Clair EW, Furst DE, Breedveld FC, Maini RN, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-1602.
21. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Finck BK, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-1593.
22. Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Finck BK, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis : two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443-1450.
23. Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Sun G, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis : A large, international, multi-center, placebo-controlled trial. Arthritis Rheum 2003;48:927-934.
24. De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis:evidence for a pathogenetic role of B cells. Arthritis Rheum 2002;46:2029-2033.
25. Verburg RJ, Toes RE, Fibbe WE, Breedveld FC, van Laar JM. High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis : a review. Hum Immunol 2002;63:627-637.